sibutramine   Click here for help

GtoPdb Ligand ID: 2586

Synonyms: Meridia® | sibutramine hydrochloride
Approved drug
sibutramine is an approved drug (FDA (1997))
Compound class: Synthetic organic
Comment: Use of sibutramine is reported to increase risk of heart attack and stroke in patients with a history of heart disease. For this reason sibutramine has been withdrawn from use in some countries.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 3.24
Molecular weight 279.18
XLogP 5.17
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
Isomeric SMILES CC(CC(C1(CCC1)c1ccc(cc1)Cl)N(C)C)C
InChI InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3
InChI Key UNAANXDKBXWMLN-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of obesity. Use of sibutramine is reported to increase risk of heart attack and stroke in patients with a history of heart disease. For this reason sibutramine has been withdrawn from use in some countries (eg US and EU). Individual national approval agencies may continue to grant marketing authorisation.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Inhibits reuptake of neurotransmitters noradenaline, 5-HT and dopamine at the neural synapse promoting a sense of satiety and decreasing appetite.
External links Click here for help